Project Grant R01HL186940
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Florida $756,228 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 4, 2025, to develop an artificial intelligence-enabled predictive model for chronic limb-threatening ischemia (CLTI) revascularization outcomes. The research addresses a critical gap in current predictive models, which demonstrate limited prognostic accuracy (area under the receiver operating...
- Federal Project Grant Award Summary Florida International University received a $1.37 million Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 21, 2025, with completion targeted for May 31, 2029. This research award funds a mechanistic investigation into mitochondrial inflammation and sepsis-induced acute lung injury (ALI), with the primary deliverable being peer-reviewed scientific...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $155,452 to the University of Connecticut Health Center under the Cardiovascular Diseases Research program (CFDA 93.837) on July 1, 2026, through June 30, 2031. This Project Grant funds mathematical modeling research designed to evaluate the epidemiological impact and cost-effectiveness of integrated HIV and non-communicable disease (NCD) screening and treatment delivery for people living with HIV (PLHIV)...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $798,698 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 10, 2025, with completion targeted for June 30, 2030. The project, titled "Cardiac Function and Proteomic Biomarkers in Individuals with Perinatal HIV Infection or Exposure," aims to comprehensively characterize cardiac dysfunction...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the Regents of the University of California, San Francisco $752,904 on June 10, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support an implementation science initiative addressing HIV and hypertension care integration in sub-Saharan Africa. The project, titled "From Evidence to Scale: Implementation Science and Simulation Modeling to Transform HIV-Hypertension Care...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $142,568 to the University of Florida Division of Sponsored Research on June 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support a K25 career development award. This grant funds a mathematician-data scientist's transition to an independent research career applying machine learning and computational phenotyping to predict early and chronic complications following lung...
- Federal Project Grant Award Summary The University of Miami, Office of Research Administration - School of Medicine, received a $381,511 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 5, 2026, with completion targeted for February 28, 2031. The award funds research investigating gasdermin D (GSDMD) as a therapeutic target for preventing vascular and cardiac dysfunction induced by neonatal...
- Federal Project Grant Award Summary The University of Virginia received a $117,552 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective January 4, 2026, with completion targeted for June 30, 2027. The award funds basic research investigating the mechanistic role of lymphatic endothelial alpha globin (HBA) in cardiometabolic heart failure (CMHF), a condition affecting over three million Americans...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Central Florida Board of Trustees a $726,035 Project Grant on September 12, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct comprehensive mapping of vagal and spinal afferent nerve innervation in rat and human hearts in both healthy and diseased states. The five-year project, scheduled for completion by June 30, 2030, will identify and characterize cardiac...
- Federal Project Grant Award Summary Florida International University received a $516,250 project grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through July 31, 2027. The award supports the development of novel RhoA nitration inhibitory peptides for treating acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). The research addresses a critical unmet medical need, as...
The University of Florida's Division of Sponsored Research received a $782,085 Project Grant award dated June 25, 2026, from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds research through February 28, 2031, to identify actionable multilevel intervention strategies designed to improve cardiovascular health outcomes among people with HIV (PWH). The project will employ advanced machine learning and artificial intelligence techniques to analyze multidimensional data integrated from electronic health records, socio-ecological databases, and physical measurements to identify syndemic patterns—clustering of multiple social drivers across social-ecological domains that disproportionately accelerate cardiovascular disease risk in PWH populations. The research addresses a critical gap in understanding how social, behavioral, and healthcare access barriers interact across individual, interpersonal, community, and societal levels to drive excess cardiovascular disease among PWH. Deliverables include identification of complex relationships and syndemic clustering among social drivers, development of realistic, evidence-based intervention targets that extend beyond individual clinical treatment to address interpersonal relationships, community contexts, and broader social structures, and actionable recommendations to inform multilevel, scalable interventions. The project will be performed at the University of Florida's Gainesville, Florida campus.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $782.1k | 6/30/26 |